Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
Clinical trial NCT00083447 · WITHDRAWN
Trial details
- NCT number
- NCT00083447
- Sponsor
- Xenova Biomedix
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-03-01
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.